Christianson Mark

Business Development DirectorNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) · full profile →Form 4 · filed Mar 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2026Sell(S)2K$0.80$2K215K
Mar 10, 2026Sell(S)12K$0.80$9K217K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001709738-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly: